July 30 (Reuters) - BioNexus Gene Lab Corp BGLC.O:
BIONEXUS GENE LAB CORP - CO AND FIDELION ANNOUNCE STRATEGIC CROSS-EQUITY PARTNERSHIP
BIONEXUS GENE LAB CORP - UNDER TERM SHEET, TO BUY EQUITY STAKE IN FIDELION AND SECURE COMMERCIAL RIGHTS TO VITAGUARD IN ASEAN
Source text: ID:nGNX130CnY
Further company coverage: BGLC.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.